1Aviv A, Aviv H. Telomercs, hidden mosaicism, loss of heterozygosity, and complex genetic traits. Hum Genet, 1998, 103:2--4.
2Aviv A, Aviv H. Telomeres and essential hypertension. Am J Hypertens, 1999, 12(4 Part 1):427--432.
3Hamet P, Thorin-Trescases N, Moreau P, et al.Workshop: excess growth and apoptosis., is hypertension a case of accelerated aging of cardiovascular cells.Hypertension, 2001, 37(2 Part 2):760--766.
4Cao Y, Li H, Mu F T, et al. Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J, 2002, 16:96-- 98.
5de Bono D P. Olovnikov's clock: telomeres and vascular biology. Heart, 1998, 80:110--111.
6Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett, 2000, 470:20--24.
7Samani N J, Boultby R, Butler R, et al. Telomere shortening in atherosclerosis. Lancet, 2001, 358:472--473.
8Minamino T, Mitsialis S A, Kourembanas S. Kourembanas S.Hypoxip extends the life span of vascular smooth muscle cell through telomerase activation. Mol Cell Biol, 2001, 21:3336--3342.
9Minamino T, Miyauchi H, Yoshida T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation, 2002,105 :1541 -- 1544.
10Kajstura J, Leri A, Finato N, et al. Myocyte proliferation in endstage cardiac failure in humans. Proc Natl Acad Sci U S A, 1998, 95:8801--8805.
